Model: | - |
---|---|
Brand: | Vitaimed |
Origin: | Made In China |
Category: | Home Supplies / Disposable Products |
Label: | - |
Price: |
-
|
Min. Order: | - |
AD Syringe for vaccine injection 0.5ml Syringe Vaccine safety syringe vaccine syringe wholesale
AD Syringe for vaccine injection
Product Name: |
|
Material: |
Medical grade high transparent PP |
Specification: |
Material: Medical grade high transparent PP
|
Instrument Classification: |
CLASS III |
Packaging Details: |
PE bag or Blister package. |
Description: |
Material: Medical grade high transparent PP
|
Extractable metal content, pH, easy oxide, ethylene oxide residue Noheat source, no cytotoxicity, no skin sensitization, no skin irritation, no acute systemic toxicity, no hemolytic reaction |
Established in 2007 in Shanghai, China, Vitaimed is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. Vitaimed product and service portfolio includes urological continence care, ostomy care, wound care, gynecological care, enteral feeding and irrigation products, and a full-service contract manufacturing business. Vitaimed products are with ISO13485, CE and FDA certificate. Vitaimed products are distributed in the United States, Germany, Greece, Italy, France, Spain, Portugal, Poland, CZ, Singapore, Thailand, Malaysia, Egypt, U.A.E., Korea, Brazil, Chile, Panama, S.Africa, Mozambique, and more than 40 other countries worldwide.
Our vaccine syringe is AD syringe for vaccine, made of medical-grade high-transparency PP, in line with international standards, large output, fast delivery, please contact us quickly.
https://www.vitaimed.com/ad-syringe-for-vaccine-injection-0-5ml-syringe/vaccine-syringe.html
VITAIMED INSTRUMENT CO., LTD | |
---|---|
Country/Region: | Shang Hai - China |
Business Nature: | Manufacturer |
Phone: | 13918638349 |
Contact: | Charles Chen (Sales Manager) |
Last Online: | 23 Dec, 2020 |